Date	Period	Revenue/Estimate	Earnings Call
Nov 16, 2022	2022/Q3	154.631M / 153.500M	--
Aug 31, 2022	2022/Q2	130.846M / 151.600M	--
May 31, 2022	2022/Q1	135.524M / 138.400M	--
Mar 22, 2022	2021/Q4	147.345M / 136.500M	--
Nov 16, 2021	2021/Q3	126.615M / 129.000M	--

DatePeriodRevenue/EstimateEarnings Call

Nov 16, 20222022/Q3154.631M / 153.500M--

Aug 31, 20222022/Q2130.846M / 151.600M--

May 31, 20222022/Q1135.524M / 138.400M--

Mar 22, 20222021/Q4147.345M / 136.500M--

Nov 16, 20212021/Q3126.615M / 129.000M--

Unlock Free Earnings Estimates

Open Account

Burning Rock Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 25 08:14 ET

Burning Rock Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 4, 2024 06:12 ET

Burning Rock Biotech | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Nov 26, 2024 08:28 ET

Burning Rock Biotech | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 23, 2024 06:11 ET

BNR Burning Rock Biotech

Burning Rock Biotech Key Stats